Drug Shortage Report for MAR-LACOSAMIDE
| Report ID | 137162 |
| Drug Identification Number | 02487810 |
| Brand name | MAR-LACOSAMIDE |
| Common or Proper name | LACOSAMIDE |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | DORMANT |
| Active Ingredient(s) | LACOSAMIDE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 Tablets |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2021-04-09 |
| Actual start date | 2021-04-09 |
| Estimated end date | 2022-08-31 |
| Actual end date | 2022-07-06 |
| Shortage status | Resolved |
| Updated date | 2023-07-13 |
| Company comments | Business reasons |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-07-13 | French | Compare |
| v6 | 2023-07-13 | English | Compare |
| v5 | 2021-08-31 | French | Compare |
| v4 | 2021-08-31 | English | Compare |
| v3 | 2021-04-10 | English | Compare |
| v2 | 2021-04-08 | French | Compare |
| v1 | 2021-04-08 | English | Compare |
Showing 1 to 7 of 7